메뉴 건너뛰기




Volumn 42, Issue 4, 2009, Pages 164-165

Atypical anorexia in a male patient accompanied by strong obsessive-compulsive symptoms successfully treated with naltrexone

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; NALTREXONE; OLANZAPINE; RISPERIDONE; NARCOTIC ANTAGONIST;

EID: 70249118221     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0028-1128114     Document Type: Article
Times cited : (4)

References (19)
  • 1
    • 42749090717 scopus 로고    scopus 로고
    • Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study
    • Amiaz R, Fostick L, Gershon A et al. Naltrexone augmentation in OCD: a double-blind placebo-controlled cross-over study. Eur Neuropsychopharmacol 2008; 18 : 455-461
    • (2008) Eur Neuropsychopharmacol , vol.18 , pp. 455-461
    • Amiaz, R.1    Fostick, L.2    Gershon, A.3
  • 2
    • 0036726611 scopus 로고    scopus 로고
    • Is there a common mechanism of serotonin dysregulation in anorexia nervosa and obsessive-compulsive disorder?
    • Barbarich N. Is there a common mechanism of serotonin dysregulation in anorexia nervosa and obsessive-compulsive disorder? Eat Weight Disord 2002; 7 : 221-231
    • (2002) Eat Weight Disord , vol.7 , pp. 221-231
    • Barbarich, N.1
  • 3
    • 15844424547 scopus 로고    scopus 로고
    • Serotonergic and dopaminergic systems in anorexia nervosa: A role for atypical antipsychotics?
    • Bosanac P, Norman T, Burrows G et al. Serotonergic and dopaminergic systems in anorexia nervosa: a role for atypical antipsychotics? J Aust N Z J Psychiatry 2005; 39 : 146-153
    • (2005) J Aust N Z J Psychiatry , vol.39 , pp. 146-153
    • Bosanac, P.1    Norman, T.2    Burrows, G.3
  • 4
    • 0032752095 scopus 로고    scopus 로고
    • Regulation of opioid receptors by opioid antagonists: Implications for rapid opioid detoxifi cation
    • Daws LC, White JM. Regulation of opioid receptors by opioid antagonists: implications for rapid opioid detoxifi cation. Addiction Biology 1999; 4 : 391-397
    • (1999) Addiction Biology , vol.4 , pp. 391-397
    • Daws, L.C.1    White, J.M.2
  • 5
    • 16544392764 scopus 로고    scopus 로고
    • The role of dopamine in obsessivecompulsive disorder: Preclinical and clinical evidence
    • Denys D, Zohar J, Westenberg HG. The role of dopamine in obsessivecompulsive disorder: preclinical and clinical evidence. J Clin Psychiatry 2004; 65 (Suppl 14) : 11-17
    • (2004) J Clin Psychiatry , vol.65 , Issue.SUPPL. 14 , pp. 11-17
    • Denys, D.1    Zohar, J.2    Westenberg, H.G.3
  • 7
    • 0027521635 scopus 로고
    • Are the eating disorders related to obsessive-compulsive disorder?
    • Hsu LK, Kaye W, Weltsin T. Are the eating disorders related to obsessive-compulsive disorder? Int J Eat Disord 1993; 14 : 305-318
    • (1993) Int J Eat Disord , vol.14 , pp. 305-318
    • Hsu, L.K.1    Kaye, W.2    Weltsin, T.3
  • 8
    • 0020572577 scopus 로고
    • Naloxone administration in obsessive-compulsive disorder: Report of two cases
    • Insel TR, Pickar D. Naloxone administration in obsessive-compulsive disorder: report of two cases. Am J Psychiatry 1983; 140 : 1219-1220
    • (1983) Am J Psychiatry , vol.140 , pp. 1219-1220
    • Insel, T.R.1    Pickar, D.2
  • 9
    • 0029977409 scopus 로고    scopus 로고
    • Behavioral eff ects of naloxone infusion in obsessive-compulsive disorder
    • Keuler DJ, Altemus M, Michelson D et al. Behavioral eff ects of naloxone infusion in obsessive-compulsive disorder. Biol Psychiatry 1996; 40 : 154-156
    • (1996) Biol Psychiatry , vol.40 , pp. 154-156
    • Keuler, D.J.1    Altemus, M.2    Michelson, D.3
  • 10
    • 0034536720 scopus 로고    scopus 로고
    • Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder
    • Kruger S, Kennedy SH. Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder. J Psychiatry Neurosci 2000; 25 : 497-508
    • (2000) J Psychiatry Neurosci , vol.25 , pp. 497-508
    • Kruger, S.1    Kennedy, S.H.2
  • 11
    • 0023293935 scopus 로고
    • Treatment of chronic anorexia nervosa with opiate blockade
    • Luby ED, Marrazzi MA, Kinzie J. Treatment of chronic anorexia nervosa with opiate blockade. J Clin Psychopharmacol 1987; 7 : 52-53
    • (1987) J Clin Psychopharmacol , vol.7 , pp. 52-53
    • Luby, E.D.1    Marrazzi, M.A.2    Kinzie, J.3
  • 12
    • 0029066210 scopus 로고
    • Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa
    • Marrazzi MA, Bacon JP, Kinzie J et al. Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa. Int Clin Psychopharmacol 1995; 10 : 163-172
    • (1995) Int Clin Psychopharmacol , vol.10 , pp. 163-172
    • Marrazzi, M.A.1    Bacon, J.P.2    Kinzie, J.3
  • 13
    • 0030912223 scopus 로고    scopus 로고
    • Endogenous codeine and morphine in anorexia and bulimia nervosa
    • Marazzi MA, Luby ED, Kinzie J et al. Endogenous codeine and morphine in anorexia and bulimia nervosa. Life Sci 1997; 60 : 1741-1747
    • (1997) Life Sci , vol.60 , pp. 1741-1747
    • Marazzi, M.A.1    Luby, E.D.2    Kinzie, J.3
  • 14
    • 0028587287 scopus 로고
    • Obsessive-compulsive spectrum disorder
    • discussion 52-53
    • MacElroy SL, Phillips KA, Keck PE Jr. Obsessive-compulsive spectrum disorder. J Clin Psychiatry 1994; 55 (Suppl) : 33-51; discussion 52-53
    • (1994) J Clin Psychiatry , vol.55 , Issue.SUPPL. , pp. 33-51
    • MacElroy, S.L.1    Phillips, K.A.2    Keck Jr., P.E.3
  • 15
    • 85047682378 scopus 로고    scopus 로고
    • Clinical uses of naltrexone: A review of the evidence
    • Modesto-Lowe V, Kirk J Van. Clinical uses of naltrexone: a review of the evidence. Exp Clin Psychopharmacol 2002; 10 : 213-227
    • (2002) Exp Clin Psychopharmacol , vol.10 , pp. 213-227
    • Modesto-Lowe, V.1    Van Kirk, J.2
  • 16
    • 0023372605 scopus 로고
    • Naloxone abolishes obsessive-compulsive behavior in Tourette's syndrome
    • Sandyk R. Naloxone abolishes obsessive-compulsive behavior in Tourette's syndrome. Int J Neurosci 1987; 35 : 93-94
    • (1987) Int J Neurosci , vol.35 , pp. 93-94
    • Sandyk, R.1
  • 17
    • 0034983220 scopus 로고    scopus 로고
    • Addiction and the brain: The role of neurotransmitters in the cause and treatment of drug dependence
    • Tomkins DM, Sellers EM. Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence. Can Med Assoc 2001; 164 : 817-821
    • (2001) Can Med Assoc , vol.164 , pp. 817-821
    • Tomkins, D.M.1    Sellers, E.M.2
  • 18
    • 0030930590 scopus 로고    scopus 로고
    • A possible new treatment approach to obsessive-compulsive disorder
    • Warneke L. A possible new treatment approach to obsessive-compulsive disorder. Can J Psychiatry 1997; 42 : 667-668
    • (1997) Can J Psychiatry , vol.42 , pp. 667-668
    • Warneke, L.1
  • 19
    • 38849209876 scopus 로고    scopus 로고
    • Serotonin-induced platelet intracellular Ca 2+ response in patients with anorexia nervosa
    • Wockel L, Koch S, Stadler C et al. Serotonin-induced platelet intracellular Ca 2+ response in patients with anorexia nervosa. Pharmacopsychiatry 2008; 41 : W10-16
    • (2008) Pharmacopsychiatry , vol.41
    • Wockel, L.1    Koch, S.2    Stadler, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.